These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


316 related items for PubMed ID: 8707271

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR, Wolters H, Havinga R, Vonk RJ, Jansen PL, Müller M, Kuipers F.
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [Abstract] [Full Text] [Related]

  • 23. Identification of a novel, sodium-dependent, reduced glutathione transporter in the rat lens epithelium.
    Kannan R, Yi JR, Tang D, Zlokovic BV, Kaplowitz N.
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2269-75. PubMed ID: 8843923
    [Abstract] [Full Text] [Related]

  • 24. Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study.
    Geng W, Schwab AJ, Horie T, Goresky CA, Pang KS.
    J Pharmacol Exp Ther; 1998 Feb; 284(2):480-92. PubMed ID: 9454788
    [Abstract] [Full Text] [Related]

  • 25. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
    Sasabe H, Tsuji A, Sugiyama Y.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
    [Abstract] [Full Text] [Related]

  • 26. Increased transcription of the regulatory subunit of gamma-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion.
    Tian L, Shi MM, Forman HJ.
    Arch Biochem Biophys; 1997 Jun 01; 342(1):126-33. PubMed ID: 9185621
    [Abstract] [Full Text] [Related]

  • 27. Determination of phase I metabolic enzyme activities in liver microsomes of Mrp2 deficient TR- and EHBR rats.
    Newton DJ, Wang RW, Evans DC.
    Life Sci; 2005 Jul 22; 77(10):1106-15. PubMed ID: 15913659
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
    Takenaka O, Horie T, Suzuki H, Sugiyama Y.
    J Pharmacol Exp Ther; 1995 Sep 22; 274(3):1362-9. PubMed ID: 7562509
    [Abstract] [Full Text] [Related]

  • 30. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR.
    Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T, Sugiyama Y.
    Am J Physiol; 1997 Jan 22; 272(1 Pt 1):G16-22. PubMed ID: 9038871
    [Abstract] [Full Text] [Related]

  • 31. The role of intracellular glutathione in methylmercury-induced toxicity in embryonic neuronal cells.
    Ou YC, White CC, Krejsa CM, Ponce RA, Kavanagh TJ, Faustman EM.
    Neurotoxicology; 1999 Oct 22; 20(5):793-804. PubMed ID: 10591515
    [Abstract] [Full Text] [Related]

  • 32. Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux.
    Meredith MJ, Cusick CL, Soltaninassab S, Sekhar KS, Lu S, Freeman ML.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):458-63. PubMed ID: 9703946
    [Abstract] [Full Text] [Related]

  • 33. Molecular characterization of a reduced glutathione transporter in the lens.
    Kannan R, Yi JR, Zlokovic BV, Kaplowitz N.
    Invest Ophthalmol Vis Sci; 1995 Aug 30; 36(9):1785-92. PubMed ID: 7635653
    [Abstract] [Full Text] [Related]

  • 34. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.
    Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T, Sugiyama Y.
    Mol Pharmacol; 1998 Jun 30; 53(6):1068-75. PubMed ID: 9614210
    [Abstract] [Full Text] [Related]

  • 35. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ.
    Cancer Res; 1993 Aug 15; 53(16):3662-6. PubMed ID: 8101766
    [Abstract] [Full Text] [Related]

  • 36. Localization of gamma-glutamylcysteine synthetase mRNA expression in mouse brain following methylmercury treatment using reverse transcription in situ PCR amplification.
    Li S, Thompson SA, Woods JS.
    Toxicol Appl Pharmacol; 1996 Sep 15; 140(1):180-7. PubMed ID: 8806884
    [Abstract] [Full Text] [Related]

  • 37. Identification of glutathione S-transferase isozymes and gamma-glutamylcysteine synthetase as negative acute-phase proteins in rat liver.
    Buetler TM.
    Hepatology; 1998 Dec 15; 28(6):1551-60. PubMed ID: 9828219
    [Abstract] [Full Text] [Related]

  • 38. Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.
    Bailey HH, Gipp JJ, Ripple M, Wilding G, Mulcahy RT.
    Cancer Res; 1992 Sep 15; 52(18):5115-8. PubMed ID: 1355406
    [Abstract] [Full Text] [Related]

  • 39. Gamma-tocopheryl quinone, not alpha-tocopheryl quinone, induces adaptive response through up-regulation of cellular glutathione and cysteine availability via activation of ATF4.
    Ogawa Y, Saito Y, Nishio K, Yoshida Y, Ashida H, Niki E.
    Free Radic Res; 2008 Jul 15; 42(7):674-87. PubMed ID: 18654882
    [Abstract] [Full Text] [Related]

  • 40. Localization by in situ hybridization of gamma-glutamylcysteine synthetase mRNA expression in rat kidney following acute methylmercury treatment.
    Li S, Thompson SA, Kavanagh TJ, Woods JS.
    Toxicol Appl Pharmacol; 1996 Nov 15; 141(1):59-67. PubMed ID: 8917676
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.